Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · IEX Real-Time Price · USD
0.798
+0.019 (2.44%)
At close: Jul 19, 2024, 4:00 PM
0.831
+0.033 (4.14%)
Pre-market: Jul 22, 2024, 8:00 AM EDT

Tevogen Bio Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021
Market Capitalization
1331,706495468
Market Cap Growth
11.16%244.47%5.78%-
Enterprise Value
1341,800530484
PE Ratio
--28.20-22.46-30.01
PB Ratio
-99.03-18.06-14.58-28.39
P/FCF Ratio
-55.30-205.40-54.20-86.93
P/OCF Ratio
-56.02-208.74-57.20-88.74
EV/EBITDA Ratio
-11.66-30.56-25.37-32.32
EV/EBIT Ratio
-11.54-30.37-25.09-32.30
EV/FCF Ratio
-55.38-216.76-57.98-89.97
Debt / Equity Ratio
-0.36-1.01-1.18-1.42
Debt / EBITDA Ratio
-0.04-1.62-1.92-1.57
Debt / FCF Ratio
-0.20-11.49-4.38-4.36
Quick Ratio
0.170.012.8010.66
Current Ratio
0.270.022.9810.74
Interest Coverage
-36.59-49.13-22.64-25.06
Return on Equity (ROE)
99.20%111.90%114.60%-
Return on Assets (ROA)
-492.30%-379.70%-8.30%-
Return on Capital (ROIC)
1218.09%-892.63%-226.59%-66.07%
Earnings Yield
-38.40%-3.55%-4.45%-3.33%
FCF Yield
-7.79%-0.49%-1.84%-1.15%
Buyback Yield / Dilution
-18.66%1.99%-0.69%-
Total Shareholder Return
-18.66%1.99%-0.69%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).